Governance
HESI is governed by the Board of Trustees, comprised of 16 representatives from the public sector and 14 representatives from the private sector. The Board provides scientific, strategic, and financial oversight for the organization. The HESI Assembly, compromised of public and private sector scientists from HESI’s scientific committees, Trustees, and HESI Emerging Issue Committee Science Advisors, elects the governing Trustees and provides input on new scientific and strategic directions for the organization.
2020-2021 HESI Board of Trustees
Dr. Jon Cook
President
Pfizer, Inc.
Dr. Martin van den Berg
Chair
Utrecht University
Dr. Anthony Holmes
Vice President
National Centre for the Replacement, Refinement and Reduction of Animals in Research
Dr. Ruth Roberts
Vice Chair
ApconiX, Ltd.
Dr. Greg Adamson
Givaudan Fragrances Corporation
Dr. Karissa Adkins
Sanofi
Dr. Scott Belanger
Procter & Gamble Company
Prof. Alan Boobis
Imperial College London
Dr. Stuart Cagen
Shell Health
Dr. Warren Casey
National Institute of Environmental Health Sciences
Dr. David Eaton
University of Washington
Dr. Patrick Guiney
University of Wisconsin
Dr. Tim Kedwards
S.C. Johnson & Son, Inc.
Dr. Jerry Lee
Lawrence J. Ellison Institute for Transformative Medicine of USC
Dr. Lois Lehman-McKeeman
Bristol-Myers Squibb Company
Dr. José Manautou
University of Connecticut
Dr. Charlene McQueen
University of Arizona
Dr. Gary Minsavage
Exxon Mobil Corporation
Dr. Graeme Moffat
Amgen, Inc.
Dr. Eliana Munarriz
University of Buenos Aires
Dr. Marc Pallardy
Université Paris-Sud
Dr. William Pennie
Takeda Pharmaceutical Company
Dr. Nathan Price
Institute for Systems Biology
Dr. Yuko Sekino
University of Tokyo
Dr. Kathleen Shelton
FMC Corporation
Dr. Pamela Spencer
Angus Chemical Company
Dr. Douglas Wolf
Syngenta Crop Protection
Dr. Watze de Wolf
European Chemicals Agency
Dr. Carole Yauk
Health Canada
